JP2014514299A5 - - Google Patents

Download PDF

Info

Publication number
JP2014514299A5
JP2014514299A5 JP2014503240A JP2014503240A JP2014514299A5 JP 2014514299 A5 JP2014514299 A5 JP 2014514299A5 JP 2014503240 A JP2014503240 A JP 2014503240A JP 2014503240 A JP2014503240 A JP 2014503240A JP 2014514299 A5 JP2014514299 A5 JP 2014514299A5
Authority
JP
Japan
Prior art keywords
methyl
hydroxy
methylsulfonyl
butanamide
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014503240A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014514299A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/051456 external-priority patent/WO2012137099A1/en
Publication of JP2014514299A publication Critical patent/JP2014514299A/ja
Publication of JP2014514299A5 publication Critical patent/JP2014514299A5/ja
Pending legal-status Critical Current

Links

JP2014503240A 2011-04-08 2012-03-27 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体 Pending JP2014514299A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161473370P 2011-04-08 2011-04-08
US61/473,370 2011-04-08
PCT/IB2012/051456 WO2012137099A1 (en) 2011-04-08 2012-03-27 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2014514299A JP2014514299A (ja) 2014-06-19
JP2014514299A5 true JP2014514299A5 (OSRAM) 2014-07-31

Family

ID=45937499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014503240A Pending JP2014514299A (ja) 2011-04-08 2012-03-27 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体

Country Status (12)

Country Link
US (1) US8809333B2 (OSRAM)
EP (1) EP2694481B1 (OSRAM)
JP (1) JP2014514299A (OSRAM)
KR (1) KR20130140164A (OSRAM)
CN (1) CN103492368A (OSRAM)
AU (1) AU2012238379C1 (OSRAM)
CA (1) CA2830866A1 (OSRAM)
IL (1) IL228798A (OSRAM)
MX (1) MX2013011432A (OSRAM)
SG (1) SG193458A1 (OSRAM)
WO (1) WO2012137099A1 (OSRAM)
ZA (1) ZA201306877B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722686B2 (en) 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
CA2782453C (en) 2009-12-16 2015-11-24 Matthew Frank Brown N-linked hydroxamic acid derivatives useful as antibacterial agents
PH12013501780A1 (en) 2011-03-07 2019-07-03 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
SG193367A1 (en) 2011-04-08 2013-10-30 Pfizer Isoxazole derivatives useful as antibacterial agents
KR20130140164A (ko) 2011-04-08 2013-12-23 화이자 인코포레이티드 항박테리아제로서 유용한 이미다졸, 피라졸 및 트라이아졸 유도체
US9663488B2 (en) * 2013-01-28 2017-05-30 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
AR097617A1 (es) * 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
MA39189A1 (fr) * 2013-12-19 2017-06-30 Actelion Pharmaceuticals Ltd Dérivés de 1h-indazole et de 1h-indole antibactériens
AR099612A1 (es) * 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
AU2015261540A1 (en) 2014-05-16 2017-01-12 Idorsia Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
TW201625569A (zh) 2014-11-19 2016-07-16 艾克泰聯製藥有限公司 抗菌性苯并噻唑衍生物
UA121225C2 (uk) * 2014-12-16 2020-04-27 Новартіс Аг СПОЛУКИ ІЗОКСАЗОЛГІДРОКСАМОВОЇ КИСЛОТИ ЯК ІНГІБІТОРИ LpxC
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
AU2017267194A1 (en) * 2016-05-17 2019-01-17 Idorsia Pharmaceuticals Ltd 6-(BUTA-1,3-DIYN-1-YL)benzo[D]thiazole derivatives
ES2643856B1 (es) * 2016-05-24 2018-08-03 Universidad Del Pais Vasco / Euskal Herriko Unibertsitatea Triazoles para la regulación de la homeostasis de calcio intracelular
PT3468957T (pt) 2016-06-14 2020-09-24 Novartis Ag Forma cristalina de (r)-4-(5-(ciclopropiletinil)isoxazol-3-il)-n-hidroxi-2-metil-2-(metilsulfonil)butanamida como um agente antibacteriano
PT3519387T (pt) * 2016-09-28 2021-09-28 Dong A St Co Ltd Derivados de tetrahidropiridina e sua utilização como agentes antibacterianos
MA48994A (fr) 2017-03-30 2020-02-05 Hoffmann La Roche Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
JP7386841B2 (ja) 2018-07-24 2023-11-27 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト イソキノリン化合物及びその使用
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
US11612606B2 (en) 2018-10-03 2023-03-28 Genentech, Inc. 8-aminoisoquinoline compounds and uses thereof
DE202021105689U1 (de) 2021-10-19 2021-11-11 Punit Kumar Dwivedi Intelligentes System zur Verbesserung des Zustands der Batterien von Elektrofahrzeugen durch maschinelles Lernen und künstliche Intelligenz

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139388A (ja) * 1984-01-20 1984-08-10 Ajinomoto Co Inc トリアゾ−ル−4−カルボン酸誘導体
US4769461A (en) 1986-09-16 1988-09-06 American Home Products Corporation Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents
US5110831A (en) 1990-11-30 1992-05-05 Du Pont Merck Pharmaceutical Company Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
IL137312A (en) 1998-02-07 2005-12-18 Vernalis Oxford Ltd Pharmaceutical anti-bacterial compositions comprising n-formyl hydroxylamine derivatives and severalsuch derivatives
GB9925470D0 (en) 1999-10-27 1999-12-29 Smithkline Beecham Plc Novel compounds
WO2002074298A1 (en) 2001-03-21 2002-09-26 Ono Pharmaceutical Co., Ltd. Il-6 production inhibitors
ES2180456B1 (es) 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
JP2004196678A (ja) * 2002-12-17 2004-07-15 Dainippon Pharmaceut Co Ltd ピラゾール系誘導体
KR101076018B1 (ko) 2003-01-08 2011-10-21 유니버시티 오브 워싱톤 항균제
GB0302431D0 (en) 2003-01-30 2003-03-05 Glaxo Group Ltd Novel compounds
CA2590115A1 (en) 2004-12-10 2006-06-15 Emory University 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
WO2006118155A1 (ja) 2005-04-27 2006-11-09 Ishihara Sangyo Kaisha, Ltd. ビフェニル誘導体又はその塩、並びにそれらを有効成分として含有する農園芸用殺菌剤
WO2006124897A2 (en) 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
US8088804B2 (en) * 2005-12-15 2012-01-03 Pfizer Inc. N-hydroxyamide derivatives possessing antibacterial activity
WO2008045671A1 (en) 2006-10-06 2008-04-17 Janssen Pharmaceutica, N.V. Matrix metalloprotease inhibitors
WO2009008905A1 (en) 2007-02-01 2009-01-15 Panthera Biopharma, Llc. Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
WO2008105515A1 (ja) 2007-02-28 2008-09-04 Taisho Pharmaceutical Co., Ltd. 新規なヒドロキサム酸誘導体
US20080234297A1 (en) 2007-03-20 2008-09-25 Changgeng Qian HSP90 Inhibitors Containing a Zinc Binding Moiety
WO2009069020A1 (en) * 2007-11-27 2009-06-04 Nxp B.V. Contact structure for an electronic circuit substrate and electronic circuit comprising said contact structure
WO2010017060A1 (en) 2008-08-04 2010-02-11 Schering Corporation Urea derivatives as antibacterial agents
WO2010024356A1 (ja) 2008-08-27 2010-03-04 大正製薬株式会社 ナフチリジン-n-オキシドを有する新規ヒドロキサム酸誘導体
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
US8722686B2 (en) * 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
JP5671545B2 (ja) * 2009-10-13 2015-02-18 ファイザー・インク 抗菌薬として有用なc結合ヒドロキサム酸誘導体
CA2782453C (en) 2009-12-16 2015-11-24 Matthew Frank Brown N-linked hydroxamic acid derivatives useful as antibacterial agents
PH12013501780A1 (en) 2011-03-07 2019-07-03 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
SG193367A1 (en) * 2011-04-08 2013-10-30 Pfizer Isoxazole derivatives useful as antibacterial agents
KR20130140164A (ko) 2011-04-08 2013-12-23 화이자 인코포레이티드 항박테리아제로서 유용한 이미다졸, 피라졸 및 트라이아졸 유도체

Similar Documents

Publication Publication Date Title
JP2014514299A5 (OSRAM)
JP2013514345A5 (OSRAM)
JP2014518220A5 (OSRAM)
JP2007530690A5 (OSRAM)
RU2012116207A (ru) Производные индола в качестве модуляторов crac
AR118840A2 (es) Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y un compuesto fungicida
JP2006518763A5 (OSRAM)
JP2010505809A5 (OSRAM)
JP2018535999A5 (OSRAM)
JP2015533157A5 (OSRAM)
JP2014517069A5 (OSRAM)
NZ609955A (en) Sgc stimulators
JP2014523880A5 (OSRAM)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2007523181A5 (OSRAM)
JP2019524705A5 (OSRAM)
IL303196A (en) Heteroaryl-substituted pyridines and methods of use
JP2015526408A5 (OSRAM)
RU2015106784A (ru) Частично насыщенное азотсодержащее гетероциклическое соединение
RU2009111113A (ru) Мидуляторы mglur5
HRP20160172T1 (hr) Spojevi koji su inhibitori metaloenzima
JP2018530591A5 (OSRAM)
JP2013510859A5 (OSRAM)
HRP20170019T1 (hr) Novi pirol-inhibitori od reduktaze s-nitrozoglutationa kao terapeutska sredstva
JP2005511543A5 (OSRAM)